Irena Loryan (I Loryan)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 11

Top Venues

Molecular pharmaceutics

Molecular psychiatry

Pharmaceutical research

Scientific reports

Uppsala Universitet Farmaceutiska fakulteten

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uppsala Universitet Farmaceutiska fakulteten Jan 17 2013

Sweden

Researcher :: Pharmaceutical Biosciences

Publications

Iva Spreitzer, Josefin Keife, Tobias Strasser, Predrag Kalaba, Jana Lubec, Winfried Neuhaus, Gert Lubec, Thierry Langer, Judith Wackerlig, Irena Loryan
Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution. International journal of molecular sciences 24 (23) (2023)
Frida Bällgren, Margareta Hammarlund-Udenaes, Irena Loryan
Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study. Pharmaceutical research (2023)
Erik Melander, Camilla Eriksson, Sara Wellens, Kimia Hosseini, Robert Fredriksson, Fabien Gosselet, Maxime Culot, Ulf Göransson, Margareta Hammarlund-Udenaes, Irena Loryan
Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro. Pharmaceutics 15 (5) (2023)
Irena Loryan, Andreas Reichel, Bo Feng, Christoffer Bundgaard, Christopher Shaffer, Cory Kalvass, Dallas Bednarczyk, Denise Morrison, Dominique Lesuisse, Edmund Hoppe, Georg C Terstappen, Holger Fischer, Li Di, Nicola Colclough, Scott Summerfield, Stephen T Buckley, Tristan S Maurer, Markus Fridén
Unbound Brain-to-Plasma Partition Coefficient, K p,uu,brain -a Game Changing Parameter for CNS Drug Discovery and Development. Pharmaceutical research 39 (7) (2022)
Dominika Luptáková, Theodosia Vallianatou, Anna Nilsson, Reza Shariatgorji, Margareta Hammarlund-Udenaes, Irena Loryan, Per E Andren
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier. Molecular psychiatry (2021)
Christos Andronis, João Pedro Silva, Eftychia Lekka, Vassilis Virvilis, Helena Carmo, Konstantina Bampali, Margot Ernst, Yang Hu, Irena Loryan, Jacques Richard, Felix Carvalho, Miroslav M Savić
Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis. Archives of toxicology 94 (8) (2020)
Elena Puris, Mikko Gynther, Elizabeth C M de Lange, Seppo Auriola, Margareta Hammarlund-Udenaes, Kristiina M Huttunen, Irena Loryan
Mechanistic Study on the Use of the l-Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets. Molecular pharmaceutics 16 (7) (2019)
Sofia Gustafsson, Dag Sehlin, Erik Lampa, Margareta Hammarlund-Udenaes, Irena Loryan
Heterogeneous drug tissue binding in brain regions of rats, Alzheimer's patients and controls: impact on translational drug development. Scientific reports 9 (1) (2019)
Siti R Yusof, Mahathir Mohd Uzid, Eng-Huat Teh, Nur Aziah Hanapi, Mazlin Mohideen, Ahmad Saifuddin Mohamad Arshad, Mohd Nizam Mordi, Irena Loryan, Margareta Hammarlund-Udenaes
Rate and extent of mitragynine and 7-hydroxymitragynine blood-brain barrier transport and their intra-brain distribution: the missing link in pharmacodynamic studies. Addiction biology 24 (5) (2018)
Irena Loryan, Edmund Hoppe, Klaus Hansen, Felix Held, Achim Kless, Klaus Linz, Virginia Marossek, Bert Nolte, Paul Ratcliffe, Derek Saunders, Rolf Terlinden, Anita Wegert, André Welbers, Olaf Will, Margareta Hammarlund-Udenaes
Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development. Molecular pharmaceutics 14 (12) (2017)
Irena Loryan, E Melander, M Svensson, M Payan, F König, B Jansson, M Hammarlund-Udenaes
In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy. Molecular psychiatry 21 (11) (2016)

Irena Loryan.css-eqlu8i{font-size:small;padding-left:4px;} (I Loryan)

Publication Activity (10 Years)

Top Topics

Top Venues

Irena Loryan (I Loryan)